Abstract:Cancer comprises malignant cells surrounded by the tumor microenvironment (TME), a dynamic ecosystem composed of heterogeneous cell populations that exert unique influences on tumor development. The immune community within the TME plays a substantial role in tumorigenesis and tumor evolution. The innate and adaptive immune cells "talk" to the tumor through ligand–receptor interactions and signaling molecules, forming a complex communication network to influence the cellular and molecular basis of cancer. Such intricate intratumoral immune composition and interactions foster the application of immunotherapies, which empower the immune system against cancer to elicit durable long-term responses in cancer patients. Single-cell technologies have allowed for the dissection and characterization of the TME to an unprecedented level, while recent advancements in bioinformatics tools have expanded the horizon and depth of high-dimensional single-cell data analysis. This review will unravel the intertwined networks between malignancy and immunity, explore the utilization of computational tools for a deeper understanding of tumor–immune communications, and discuss the application of these approaches to aid in diagnosis or treatment decision making in the clinical setting, as well as the current challenges faced by the researchers with their potential future improvements.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to deeply understand and analyze the tumor microenvironment (TME) and its relationship with immunotherapy through single - cell technology. Specifically, the paper focuses on the following aspects: 1. **Complexity of the tumor microenvironment**: The tumor microenvironment is a dynamic ecosystem composed of multiple cell types, and these cell types have unique impacts on tumor development and evolution. In particular, immune cells play an important role in tumorigenesis and evolution, and they conduct complex communication with tumor cells through ligand - receptor interactions and signal molecules. 2. **Differences in response rates to immune checkpoint inhibitor (ICI) therapy**: Although immune checkpoint inhibitors (such as CTLA - 4 and PD - 1 monoclonal antibodies) have significantly improved cancer treatment, different types of cancers have very different response rates to these therapies. For example, the response rate of pancreatic cancer is only 4%, while the response rate of melanoma is as high as 70%. Therefore, a more comprehensive understanding of cancer biology, especially the cellular composition of the TME and the interactions between tumor and immune cells, is required to improve patients' response rates to ICI therapy. 3. **Advantages of single - cell technology**: Traditional bulk analysis methods cannot capture the subtle differences between cells, masking the key biological details of rare subpopulations and cell states. Single - cell technology can reveal these details through high - resolution gene expression profiling, thereby more accurately defining and distinguishing patient heterogeneity and different treatment responses. 4. **Application of bioinformatics tools**: With the increase in the amount of single - cell data generation, it is particularly important to develop efficient bioinformatics tools. These tools can help researchers extract biologically relevant insights from a large amount of complex data, such as identifying drug targets and biomarkers, thereby guiding clinical applications. In summary, this paper aims to deeply analyze the complex network of the tumor microenvironment through single - cell technology and bioinformatics tools, optimize immunotherapy strategies, and improve patients' response rates to immune checkpoint inhibitor therapy.

Single-Cell Informatics for Tumor Microenvironment and Immunotherapy

Applications of Single-Cell Omics in Tumor Immunology

Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy

Single-Cell Profiling to Explore Immunological Heterogeneity of Tumor Microenvironment in Breast Cancer

Modelling the tumor immune microenvironment for precision immunotherapy

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment

Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis

Application of single-cell sequencing to the research of tumor microenvironment

Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer

Advancements in technology for characterizing the tumor immune microenvironment

Tumor immunology in the age of single-cell genomics

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Biophysical and biochemical aspects of immune cell–tumor microenvironment interactions

Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses

Integrative insights and clinical applications of single-cell sequencing in cancer immunotherapy

Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies

Deciphering Innate Immune Cell-Tumor Microenvironment Crosstalk at a Single-Cell Level

TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment

Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment

Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies